Antosik, P.; Durślewicz, J.; Smolińska-Świtała, M.; Podemski, J.; Podemska, E.; Neska-Długosz, I.; Jóźwicki, J.; Grzanka, D.
KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma. Cancers 2025, 17, 804.
https://doi.org/10.3390/cancers17050804
AMA Style
Antosik P, Durślewicz J, Smolińska-Świtała M, Podemski J, Podemska E, Neska-Długosz I, Jóźwicki J, Grzanka D.
KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma. Cancers. 2025; 17(5):804.
https://doi.org/10.3390/cancers17050804
Chicago/Turabian Style
Antosik, Paulina, Justyna Durślewicz, Marta Smolińska-Świtała, Jonasz Podemski, Edyta Podemska, Izabela Neska-Długosz, Jakub Jóźwicki, and Dariusz Grzanka.
2025. "KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma" Cancers 17, no. 5: 804.
https://doi.org/10.3390/cancers17050804
APA Style
Antosik, P., Durślewicz, J., Smolińska-Świtała, M., Podemski, J., Podemska, E., Neska-Długosz, I., Jóźwicki, J., & Grzanka, D.
(2025). KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma. Cancers, 17(5), 804.
https://doi.org/10.3390/cancers17050804